Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Clues into the molecular genetics of aging revealed

Jan. 19, 1998

Elan and Novartis to develop new formulation of Novartis drug

Jan. 19, 1998

Idun licenses novel protein technology from Thomas Jefferson University

Jan. 15, 1998

Abgenix and Pfizer collaborate on XenoMouse antibodies

Jan. 14, 1998

Advanced Polymer Systems and Pharmacia & Upjohn collaborate on new drug formulation

Jan. 13, 1998

Endorex, Elan agree to form joint venture for vaccine development

Jan. 12, 1998

NIH communication reports contemplation of licensing agreement

Jan. 9, 1998

Genetronics' electroporation therapy further evaluated in French trial

Jan. 9, 1998

Report of ThromboSol efficacy presented at hematology congress

Jan. 9, 1998

BioChem Pharma/Scriptgen conclude licensing and equity agreements

Jan. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...